サンプル依頼リスト カート
  • English
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1781928

感染症診断市場：製品・サービス別、検査タイプ別、サンプルタイプ別、疾患タイプ別、技術別、エンドユーザー別、国別、地域別- 産業分析、市場規模、市場シェア、2024～2032年予測

Infectious Disease Diagnostic Market, By Product & Service, By Type of Testing, By Sample Type, By Disease Type, By Technology, By End User, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2024-2032

出版日
ページ情報
英文 399 Pages
納期
2～3営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=148.67円
感染症診断市場：製品・サービス別、検査タイプ別、サンプルタイプ別、疾患タイプ別、技術別、エンドユーザー別、国別、地域別- 産業分析、市場規模、市場シェア、2024～2032年予測
出版日: 2025年06月04日
発行: AnalystView Market Insights
ページ情報: 英文 399 Pages
納期: 2～3営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

レポートハイライト

感染症診断市場規模は2024年に229億1,800万米ドルとなり、2024～2032年にかけてCAGR 8.2％で拡大

感染症診断市場-市場力学

感染症罹患率の増加

世界の感染症罹患率の増加は、感染症診断市場の主要促進要因です。人口密度の上昇、世界の旅行、気候変動などの要因が病原体の急速な拡散に寄与しています。さらに、抗生物質耐性株や新型感染症の出現により、正確で迅速な診断ツールの必要性が高まっています。早期かつ正確な診断により、タイムリーな治療が可能となり、疾病伝播が減少し、患者の転帰が改善されます。その結果、ヘルスケアシステムは先進的診断技術への投資を増やし、感染症の検出と管理における市場の成長と技術革新に拍車をかけています。

感染症診断市場-主要な洞察

当社のリサーチアナリストによると、世界の感染症診断市場は、2024～2032年にかけて約8.2%のCAGRで開発される見込みです。

2023年の製品・サービス別では、試薬、キット、消耗品カテゴリーが市場を独占しています。

技術別では、ポリメラーゼ連鎖反応（PCR）セグメントが2023年に最も収益を上げました。

地域別では、2023年に北米のが最も高い収益を上げた地域でした。

感染症診断市場-セグメンテーション分析

世界の感染症診断市場は7つのカテゴリーに分類されます：製品・サービス、エンドユーザー、検査タイプ、サンプルタイプ、疾患タイプ、技術、地域。

感染症診断市場は、製品・サービス別に、試薬・キット・消耗品、機器、ソフトウェアサービスの3つに分類されます。試薬、キット、消耗品には、診断検査を実施するために必要不可欠な化学品、検査キット、材料が含まれます。機器とは、PCR装置、免疫測定分析装置、顕微鏡など、診断手順を実行するために使用される装置や機械を指します。ソフトウェアとサービスには、データ管理ツール、診断ソフトウェア、検査精度を高め、検査室のワークフローを合理化するサポートサービスが含まれます。これらのセグメントのうち、試薬、キット、消耗品は、検査室や病院でのルーチン検査で繰り返し需要があるため、市場を独占しています。高い消費率と検査精度における重要な役割により、このセグメントは感染症診断薬市場の主要な収益促進要因となっています。

感染症診断市場は、技術別に免疫診断、臨床微生物学、ポリメラーゼ連鎖反応（PCR）、等温核酸増幅技術、DNAシーケンス＆次世代シーケンス（NGS）、DNAマイクロアレイ、その他の新興技術に分類されます。免疫診断学では、感染症を特定するために抗原や抗体を検出します。臨床微生物学は、微生物の培養と同定に重点を置きます。PCRや等温核酸増幅は、病原体のDNAやRNAを増幅して正確に検出する分子技術です。DNAシーケンスとNGSは、病原体の同定と耐性プロファイリングのための包括的な遺伝子情報を提供し、DNAマイクロアレイは大規模な遺伝子発現分析を可能にします。これらのうち、ポリメラーゼ連鎖反応（PCR）は、その高い感度、特異性、迅速な所要時間、世界中の臨床検査室での広範な採用により市場を独占しており、正確な感染症検出のための好ましい選択肢となっています。

感染症診断市場-地理的洞察

感染症診断市場は、北米、アジア太平洋、ラテンアメリカ、欧州、中東・アフリカのに分布しています。これらの地域は、ビジネスをもたらす国に基づいてさらに分割されます。

北米は感染症診断市場において支配的な地域であり、先進的ヘルスケアインフラ、高い医療費、最先端の診断技術の普及がその要因となっています。特に米国は、研究開発への多額の投資、強力な規制支援、大手診断薬企業の存在により市場をリードしています。同地域では疾病の早期発見が重視され、感染症の流行が増加し、ヘルスケア従事者の意識が高まっていることが、市場の成長をさらに後押ししています。さらに、診断能力を向上させるための政府の取り組みや、迅速なポイントオブケア検査に対する需要の高まりも、北米のがこの市場で圧倒的な地位を占める要因となっています。

アジア太平洋のも感染症診断薬の主要市場のひとつであり、人口の増加、ヘルスケアへのアクセスの向上、感染症負担の増加によって急速な成長を遂げています。中国やインドのような国々は、医療インフラの拡大や医療サービスへの政府支出の増加により需要を牽引しています。この地域は、意識の高まり、診断施設の改善、より良いヘルスケアを求める中間層の増加などの恩恵を受けています。さらに、結核、デング熱、COVID-19などの感染症の発生は、強固な診断ソリューションの必要性を強調しており、アジア太平洋のはこのセグメントで急成長している戦略的に重要な市場となっています。

感染症診断市場-競合情勢

感染症診断市場は、アボット社、F.ホフマン・ラ・ロシュ社、Thermo Fisher Scientific、バイオメリュー社など、広範な製品ポートフォリオと継続的な技術革新によって優位を占める大手企業によって形成されています。これらの企業は研究開発に多額の投資を行い、診断精度、スピード、自動化を強化し、厳しい規制基準を満たしています。競合環境は、分子診断やポイントオブケア検査技術に注力する新興企業にも牽引されています。戦略的買収や提携は、各社が地理的プレゼンスと技術的能力の拡大を図り、最終的に感染症の検出と患者の転帰を世界中で改善しようとする中で一般的に行われています。

目次

第1章 感染症診断市場概要

  • 調査範囲
  • 市場推定年数

第2章 エグゼクティブサマリー

  • 市場内訳
  • 競合考察

第3章 感染症診断の主要市場動向

  • 市場促進要因
  • 市場抑制要因
  • 市場機会
  • 市場の将来動向

第4章 感染症診断産業研究

  • PEST分析
  • ポーターのファイブフォース分析
  • 成長展望マッピング
  • 規制枠組み分析

第5章 感染症診断市場：COVID-19の影響分析

  • COVID-19前の影響分析
  • COVID-19後の影響分析

第6章 感染症診断市場情勢

  • 感染症診断市場シェア分析（2023年）
  • 主要メーカー別内訳データ
    • 既存企業の分析
    • 新興企業の分析

第7章 感染症診断市場-製品・サービス別

  • 概要
    • 製品・サービス別セグメントシェア分析
    • 試薬、キット、消耗品
    • 機器
    • ソフトウェアとサービス

第8章 感染症診断市場-検査タイプ別

  • 概要
    • 検査タイプ別セグメントシェア分析
    • 臨床検査
    • POCテスト

第9章 感染症診断市場-サンプルタイプ別

  • 概要
    • サンプルタイプ別セグメントシェア分析
    • 血液、血清、血漿
    • 尿
    • その他のサンプルタイプ

第10章 感染症診断市場-疾患別

  • 概要
    • 疾患別セグメントシェア分析
    • 肝炎
      • B型肝炎
      • C型肝炎
      • その他の肝炎疾患
    • HIV
    • 院内感染
    • 蚊媒介性疾患
    • HPV
    • クラミジア・トラコマティス
    • 淋菌
    • 結核
    • インフルエンザ
    • 梅毒
    • COVID-19
    • その他の感染症

第11章 感染症診断市場-技術別

  • 概要
    • 技術別セグメントシェア分析
    • 免疫診断
    • 臨床微生物学
    • ポリメラーゼ連鎖反応（PCR）
    • 等温核酸増幅技術
    • DNAシーケンス＆次世代シーケンス（NGS）
    • DNAマイクロアレイ
    • その他の新興技術

第12章 感染症診断市場-エンドユーザー別

  • 概要
    • エンドユーザー別セグメントシェア分析
    • 診断ラボ
    • 病院とクリニック
    • 学術研究機関
    • その他

第13章 感染症診断市場-地域

  • イントロダクション
  • 北米
    • 概要
    • 北米の主要メーカー
    • 米国
    • カナダ
  • 欧州
    • 概要
    • 欧州の主要メーカー
    • ドイツ
    • イタリア
    • 英国
    • フランス
    • ロシア
    • オランダ
    • スウェーデン
    • ポーランド
    • その他
  • アジア太平洋
    • 概要
    • アジア太平洋の主要メーカー
    • インド
    • 中国
    • 日本
    • 韓国
    • オーストラリア
    • タイ
    • インドネシア
    • フィリピン
    • その他
  • ラテンアメリカ
    • 概要
    • ラテンアメリカの主要メーカー
    • ブラジル
    • メキシコ
    • アルゼンチン
    • コロンビア
    • その他
  • 中東・アフリカ
    • 概要
    • 中東・アフリカの主要メーカー
    • サウジアラビア
    • アラブ首長国連邦
    • イスラエル
    • トルコ
    • アルジェリア
    • エジプト
    • その他

第14章 主要ベンダー分析-感染症診断産業

  • 競合ダッシュボード
  • 企業プロファイル
    • F. Hoffmann-La Roche Ltd.
    • Abbott
    • Biomerieux
    • Siemens Healthineers Ag
    • Danaher
    • Thermo Fisher Scientific Inc.
    • Hologic, Inc.
    • Becton, Dickinson And Company
    • Revvity
    • Qiagen
    • Seegene Inc.
    • Quidelortho Corporation
    • Grifols, SA
    • Diasorin SPA
    • Bio-Rad Laboratories, Inc.
    • Sysmex Corporation
    • その他

第15章 アナリストの全方位展望

目次
Product Code: ANV5370

REPORT HIGHLIGHT

Infectious Disease Diagnostic Market size was valued at USD 22,918 Million in 2024, expanding at a CAGR of 8.2% from 2024 to 2032.

Infectious Disease Diagnostic refers to the process and methods used to detect, identify, and confirm the presence of pathogens such as bacteria, viruses, fungi, or parasites that cause infectious diseases in humans or animals. This diagnostic process employs various techniques, including laboratory tests like culture, microscopy, molecular assays (e.g., PCR), antigen detection, and serology. Accurate and timely infectious disease diagnostics are crucial for appropriate treatment decisions, infection control, and epidemiological surveillance. These diagnostics help differentiate infectious agents, monitor disease progression, and guide public health interventions to prevent outbreaks and manage patient care effectively.

Infectious Disease Diagnostic Market- Market Dynamics

Growing Prevalence of Infectious Diseases

The increasing incidence of infectious diseases worldwide is a key driver for the infectious disease diagnostics market. Factors such as rising population density, global travel, and climate change contribute to the rapid spread of pathogens. Additionally, the emergence of antibiotic-resistant strains and novel infectious agents has intensified the need for accurate, rapid diagnostic tools. Early and precise diagnosis enables timely treatment, reducing disease transmission and improving patient outcomes. Consequently, healthcare systems are investing more in advanced diagnostic technologies, fueling market growth and innovation in infectious disease detection and management.

Infectious Disease Diagnostic Market- Key Insights

According to our research analyst, the global Infectious Disease Diagnostic Market is expected to develop at a CAGR of approximately 8.2% between 2024-2032.

Segmented by Product And Service in 2023, the Reagents, Kits, And Consumables category dominated the market.

Based on Technology, the Polymerase Chain Reaction (PCR) segment generated the most income in 2023.

On the basis of region, in 2023, North America was the region with the highest revenue.

Infectious Disease Diagnostic Market- Segmentation Analysis:

The global Infectious Disease Diagnostic Market is divided into Seven categories: Product & Service, End User, Type of Testing, Sample Type, Disease Type, Technology, and Region.

The infectious disease diagnostics market is segmented by product and service into three main categories: reagents, kits, and consumables; instruments; and software & services. Reagents, kits, and consumables include the essential chemicals, test kits, and materials required for conducting diagnostic tests. Instruments refer to the devices and machinery used to perform diagnostic procedures, such as PCR machines, immunoassay analyzers, and microscopes. Software & services encompass data management tools, diagnostic software, and support services that enhance test accuracy and streamline laboratory workflows. Among these segments, reagents, kits, and consumables dominate the market due to their recurring demand in laboratories and hospitals for routine testing. Their high consumption rate and critical role in test accuracy make this segment a primary revenue driver in the infectious disease diagnostics market.

The infectious disease diagnostics market is categorized by technology into several key segments: immunodiagnostics, clinical microbiology, polymerase chain reaction (PCR), isothermal nucleic acid amplification technology, DNA sequencing & next-generation sequencing (NGS), DNA microarray, and other emerging technologies. Immunodiagnostics involves detecting antigens or antibodies to identify infections. Clinical microbiology focuses on culturing and identifying microorganisms. PCR and isothermal nucleic acid amplification are molecular techniques amplifying pathogen DNA or RNA for precise detection. DNA sequencing and NGS provide comprehensive genetic information for pathogen identification and resistance profiling, while DNA microarrays enable large-scale gene expression analysis. Among these, polymerase chain reaction (PCR) dominates the market due to its high sensitivity, specificity, rapid turnaround time, and widespread adoption in clinical laboratories worldwide, making it the preferred choice for accurate infectious disease detection.

Infectious Disease Diagnostic Market- Geographical Insights

Geographically, the Infectious Disease Diagnostic Market is distributed throughout North America, Asia Pacific, Latin America, Europe, the Middle East, and Africa. These regions are further divided based on the nations bringing in business.

North America is a dominant region in the infectious disease diagnostics market, driven by advanced healthcare infrastructure, high healthcare expenditure, and widespread adoption of cutting-edge diagnostic technologies. The U.S., in particular, leads due to significant investments in research and development, strong regulatory support, and the presence of major diagnostic companies. The region's focus on early disease detection, rising prevalence of infectious diseases, and growing awareness among healthcare providers further fuel market growth. Additionally, government initiatives to improve diagnostic capabilities and the increasing demand for rapid point-of-care testing contribute to North America's commanding position in this market.

Asia Pacific is another key market for infectious disease diagnostics, experiencing rapid growth fueled by a large and growing population, increasing healthcare access, and rising infectious disease burden. Countries like China and India drive demand due to expanding healthcare infrastructure and increased government spending on healthcare services. The region benefits from rising awareness, improved diagnostic facilities, and a growing middle class seeking better healthcare. Additionally, the outbreak of infectious diseases such as tuberculosis, dengue, and COVID-19 has emphasized the need for robust diagnostic solutions, positioning Asia Pacific as a fast-growing and strategically important market in this sector.

Infectious Disease Diagnostic Market- Competitive Landscape:

The infectious disease diagnostic market is shaped by leading players such as Abbott, F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., and bioMerieux, which dominate through extensive product portfolios and continuous innovation. These companies invest heavily in research and development to enhance diagnostic accuracy, speed, and automation, meeting stringent regulatory standards. The competitive environment is also driven by emerging firms focusing on molecular diagnostics and point-of-care testing technologies. Strategic acquisitions and collaborations are common as companies seek to expand their geographic presence and technological capabilities, ultimately improving infectious disease detection and patient outcomes worldwide.

Recent Developments:

In March 2025, Abbott launched a new rapid molecular test for respiratory infections that delivers results in under 30 minutes, enhancing point-of-care diagnostics.

In January 2024, Roche expanded its diagnostic testing portfolio with the introduction of a highly sensitive COVID-19 and flu multiplex assay, improving simultaneous detection of multiple pathogens.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL INFECTIOUS DISEASE DIAGNOSTIC MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

  • F. Hoffmann-La Roche Ltd.
  • Abbott
  • Biomerieux
  • Siemens Healthineers Ag
  • Danaher
  • Thermo Fisher Scientific Inc.
  • Hologic, Inc.
  • Becton, Dickinson And Company
  • Revvity
  • Qiagen
  • Seegene Inc.
  • Quidelortho Corporation
  • Grifols, S.A.
  • Diasorin S.P.A.
  • Bio-Rad Laboratories, Inc.
  • Sysmex Corporation
  • Others

GLOBAL INFECTIOUS DISEASE DIAGNOSTIC MARKET, BY PRODUCT & SERVICE - MARKET ANALYSIS, 2019 - 2032

  • Reagents, Kits, And Consumables
  • Instruments
  • Software & Services

GLOBAL INFECTIOUS DISEASE DIAGNOSTIC MARKET, BY END USER - MARKET ANALYSIS, 2019 - 2032

  • Diagnostic Laboratories
  • Hospitals & Clinics
  • Academic Research Institutes
  • Other End Users

GLOBAL INFECTIOUS DISEASE DIAGNOSTIC MARKET, BY TYPE OF TESTING - MARKET ANALYSIS, 2019 - 2032

  • Laboratory Testing
  • POC Testing

GLOBAL INFECTIOUS DISEASE DIAGNOSTIC MARKET, BY DISEASE TYPE - MARKET ANALYSIS, 2019 - 2032

  • Hepatitis
  • Hepatitis B
  • Hepatitis C
  • Other Hepatitis Diseases
  • HIV
  • Hospital-Acquired Infections
  • Mosquito-Borne Diseases
  • HPV
  • Chlamydia Trachomatis
  • Neisseria Gonorrhea
  • Tuberculosis
  • Influenza
  • Syphilis
  • Covid-19
  • Other Infectious Diseases

GLOBAL INFECTIOUS DISEASE DIAGNOSTIC MARKET, BY TECHNOLOGY - MARKET ANALYSIS, 2019 - 2032

  • Immunodiagnostics
  • Clinical Microbiology
  • Polymerase Chain Reaction
  • Isothermal Nucleic Acid Amplification Technology
  • Dna Sequencing & Next-Generation Sequencing
  • Dna Microarray
  • Other Technologies

GLOBAL INFECTIOUS DISEASE DIAGNOSTIC MARKET, BY SAMPLE TYPE - MARKET ANALYSIS, 2019 - 2032

  • Blood, Serum, And Plasma
  • Urine
  • Other Sample Types

GLOBAL INFECTIOUS DISEASE DIAGNOSTIC MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

  • North America
  • The U.S.
  • Canada
  • Europe
  • Germany
  • France
  • Italy
  • Spain
  • United Kingdom
  • Russia
  • Netherlands
  • Sweden
  • Poland
  • Rest of Europe
  • Asia Pacific
  • India
  • China
  • South Korea
  • Japan
  • Australia
  • Thailand
  • Indonesia
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • United Arab Emirates
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. Infectious Disease Diagnostic Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Infectious Disease Diagnostic Market Snippet by Product & Service
    • 2.1.2. Infectious Disease Diagnostic Market Snippet by Type of Testing
    • 2.1.3. Infectious Disease Diagnostic Market Snippet by Sample Type
    • 2.1.4. Infectious Disease Diagnostic Market Snippet by Disease Type
    • 2.1.5. Infectious Disease Diagnostic Market Snippet by Technology
    • 2.1.6. Infectious Disease Diagnostic Market Snippet by End User
    • 2.1.7. Infectious Disease Diagnostic Market Snippet by Country
    • 2.1.8. Infectious Disease Diagnostic Market Snippet by Region
  • 2.2. Competitive Insights

3. Infectious Disease Diagnostic Key Market Trends

  • 3.1. Infectious Disease Diagnostic Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Infectious Disease Diagnostic Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Infectious Disease Diagnostic Market Opportunities
  • 3.4. Infectious Disease Diagnostic Market Future Trends

4. Infectious Disease Diagnostic Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Infectious Disease Diagnostic Market: COVID-19 Impact Analysis

  • 5.1. Pre-COVID-19 Impact Analysis
  • 5.2. Post-COVID-19 Impact Analysis
    • 5.2.1. Top Performing Segments
    • 5.2.2. Marginal Growth Segments
    • 5.2.3. Top Looser Segments
    • 5.2.4. Marginal Loss Segments

6. Infectious Disease Diagnostic Market Landscape

  • 6.1. Infectious Disease Diagnostic Market Share Analysis, 2023
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Infectious Disease Diagnostic Market - By Product & Service

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Product & Service, 2023 & 2032 (%)
    • 7.1.2. Reagents, Kits, And Consumables
    • 7.1.3. Instruments
    • 7.1.4. Software & Services

8. Infectious Disease Diagnostic Market - By Type of Testing

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Type of Testing, 2023 & 2032 (%)
    • 8.1.2. Laboratory Testing
    • 8.1.3. POC Testing

9. Infectious Disease Diagnostic Market - By Sample Type

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By Sample Type, 2023 & 2032 (%)
    • 9.1.2. Blood, Serum, And Plasma
    • 9.1.3. Urine
    • 9.1.4. Other Sample Types

10. Infectious Disease Diagnostic Market - By Disease Type

  • 10.1. Overview
    • 10.1.1. Segment Share Analysis, By Disease Type, 2023 & 2032 (%)
    • 10.1.2. Hepatitis
      • 10.1.2.1. Hepatitis B
      • 10.1.2.2. Hepatitis C
      • 10.1.2.3. Other Hepatitis Diseases
    • 10.1.3. HIV
    • 10.1.4. Hospital-Acquired Infections
    • 10.1.5. Mosquito-Borne Diseases
    • 10.1.6. HPV
    • 10.1.7. Chlamydia Trachomatis
    • 10.1.8. Neisseria Gonorrhea
    • 10.1.9. Tuberculosis
    • 10.1.10. Influenza
    • 10.1.11. Syphilis
    • 10.1.12. Covid-19
    • 10.1.13. Other Infectious Diseases

11. Infectious Disease Diagnostic Market - By Technology

  • 11.1. Overview
    • 11.1.1. Segment Share Analysis, By Technology, 2023 & 2032 (%)
    • 11.1.2. Immunodiagnostics
    • 11.1.3. Clinical Microbiology
    • 11.1.4. Polymerase Chain Reaction
    • 11.1.5. Isothermal Nucleic Acid Amplification Technology
    • 11.1.6. DNA Sequencing & Next-Generation Sequencing
    • 11.1.7. DNA Microarray
    • 11.1.8. Other Technologies

12. Infectious Disease Diagnostic Market - By End User

  • 12.1. Overview
    • 12.1.1. Segment Share Analysis, By Technology, 2023 & 2032 (%)
    • 12.1.2. Diagnostic Laboratories
    • 12.1.3. Hospitals & Clinics
    • 12.1.4. Academic Research Institutes
    • 12.1.5. Other End Users

13. Infectious Disease Diagnostic Market- By Geography

  • 13.1. Introduction
    • 13.1.1. Segment Share Analysis, By Geography, 2023 & 2032 (%)
  • 13.2. North America
    • 13.2.1. Overview
    • 13.2.2. Infectious Disease Diagnostic Key Manufacturers in North America
    • 13.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 13.2.4. North America Market Size and Forecast, By Product & Service, 2019 - 2032 (US$ Million)
    • 13.2.5. North America Market Size and Forecast, By Type of Testing, 2019 - 2032 (US$ Million)
    • 13.2.6. North America Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
    • 13.2.7. North America Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
    • 13.2.8. North America Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 13.2.9. North America Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 13.2.10. U.S.
      • 13.2.10.1. Overview
      • 13.2.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 13.2.10.3. U.S. Market Size and Forecast, By Product & Service, 2019 - 2032 (US$ Million)
      • 13.2.10.4. U.S. Market Size and Forecast, By Type of Testing, 2019 - 2032 (US$ Million)
      • 13.2.10.5. U.S. Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
      • 13.2.10.6. U.S. Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 13.2.10.7. U.S. Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 13.2.10.8. U.S. Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 13.2.11. Canada
      • 13.2.11.1. Overview
      • 13.2.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 13.2.11.3. Canada Market Size and Forecast, By Product & Service, 2019 - 2032 (US$ Million)
      • 13.2.11.4. Canada Market Size and Forecast, By Type of Testing, 2019 - 2032 (US$ Million)
      • 13.2.11.5. Canada Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
      • 13.2.11.6. Canada Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 13.2.11.7. Canada Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 13.2.11.8. Canada Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 13.3. Europe
    • 13.3.1. Overview
    • 13.3.2. Infectious Disease Diagnostic Key Manufacturers in Europe
    • 13.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 13.3.4. Europe Market Size and Forecast, By Product & Service, 2019 - 2032 (US$ Million)
    • 13.3.5. Europe Market Size and Forecast, By Type of Testing, 2019 - 2032 (US$ Million)
    • 13.3.6. Europe Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
    • 13.3.7. Europe Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
    • 13.3.8. Europe Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 13.3.9. Europe Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 13.3.10. Germany
      • 13.3.10.1. Overview
      • 13.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 13.3.10.3. Germany Market Size and Forecast, By Product & Service, 2019 - 2032 (US$ Million)
      • 13.3.10.4. Germany Market Size and Forecast, By Type of Testing, 2019 - 2032 (US$ Million)
      • 13.3.10.5. Germany Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
      • 13.3.10.6. Germany Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 13.3.10.7. Germany Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 13.3.10.8. Germany Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 13.3.11. Italy
      • 13.3.11.1. Overview
      • 13.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 13.3.11.3. Italy Market Size and Forecast, By Product & Service, 2019 - 2032 (US$ Million)
      • 13.3.11.4. Italy Market Size and Forecast, By Type of Testing, 2019 - 2032 (US$ Million)
      • 13.3.11.5. Italy Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
      • 13.3.11.6. Italy Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 13.3.11.7. Italy Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 13.3.11.8. Italy Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 13.3.12. United Kingdom
      • 13.3.12.1. Overview
      • 13.3.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 13.3.12.3. United Kingdom Market Size and Forecast, By Product & Service, 2019 - 2032 (US$ Million)
      • 13.3.12.4. United Kingdom Market Size and Forecast, By Type of Testing, 2019 - 2032 (US$ Million)
      • 13.3.12.5. United Kingdom Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
      • 13.3.12.6. United Kingdom Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 13.3.12.7. United Kingdom Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 13.3.12.8. United Kingdom Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 13.3.13. France
      • 13.3.13.1. Overview
      • 13.3.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 13.3.13.3. France Market Size and Forecast, By Product & Service, 2019 - 2032 (US$ Million)
      • 13.3.13.4. France Market Size and Forecast, By Type of Testing, 2019 - 2032 (US$ Million)
      • 13.3.13.5. France Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
      • 13.3.13.6. France Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 13.3.13.7. France Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 13.3.13.8. France Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 13.3.14. Russia
      • 13.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 13.3.14.2. Russia Market Size and Forecast, By Product & Service, 2019 - 2032 (US$ Million)
      • 13.3.14.3. Russia Market Size and Forecast, By Type of Testing, 2019 - 2032 (US$ Million)
      • 13.3.14.4. Russia Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
      • 13.3.14.5. Russia Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 13.3.14.6. Russia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 13.3.14.7. Russia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 13.3.15. Netherlands
      • 13.3.15.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 13.3.15.2. Netherlands Market Size and Forecast, By Product & Service, 2019 - 2032 (US$ Million)
      • 13.3.15.3. Netherlands Market Size and Forecast, By Type of Testing, 2019 - 2032 (US$ Million)
      • 13.3.15.4. Netherlands Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
      • 13.3.15.5. Netherlands Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 13.3.15.6. Netherlands Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 13.3.15.7. Netherlands Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 13.3.16. Sweden
      • 13.3.16.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 13.3.16.2. Sweden Market Size and Forecast, By Product & Service, 2019 - 2032 (US$ Million)
      • 13.3.16.3. Sweden Market Size and Forecast, By Type of Testing, 2019 - 2032 (US$ Million)
      • 13.3.16.4. Sweden Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
      • 13.3.16.5. Sweden Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 13.3.16.6. Sweden Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 13.3.16.7. Sweden Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 13.3.17. Poland
      • 13.3.17.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 13.3.17.2. Poland Market Size and Forecast, By Product & Service, 2019 - 2032 (US$ Million)
      • 13.3.17.3. Poland Market Size and Forecast, By Type of Testing, 2019 - 2032 (US$ Million)
      • 13.3.17.4. Poland Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
      • 13.3.17.5. Poland Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 13.3.17.6. Poland Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 13.3.17.7. Poland Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 13.3.18. Rest of Europe
      • 13.3.18.1. Overview
      • 13.3.18.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 13.3.18.3. Rest of the Europe Market Size and Forecast, By Product & Service, 2019 - 2032 (US$ Million)
      • 13.3.18.4. Rest of the Europe Market Size and Forecast, By Type of Testing, 2019 - 2032 (US$ Million)
      • 13.3.18.5. Rest of the Europe Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
      • 13.3.18.6. Rest of the Europe Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 13.3.18.7. Rest of the Europe Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 13.3.18.8. Rest of the Europe Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 13.4. Asia Pacific (APAC)
    • 13.4.1. Overview
    • 13.4.2. Infectious Disease Diagnostic Key Manufacturers in Asia Pacific
    • 13.4.3. Asia Pacific Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 13.4.4. Asia Pacific Market Size and Forecast, By Product & Service, 2019 - 2032 (US$ Million)
    • 13.4.5. Asia Pacific Market Size and Forecast, By Type of Testing, 2019 - 2032 (US$ Million)
    • 13.4.6. Asia Pacific Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
    • 13.4.7. Asia Pacific Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
    • 13.4.8. Asia Pacific Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 13.4.9. Asia Pacific Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 13.4.10. India
      • 13.4.10.1. Overview
      • 13.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 13.4.10.3. India Market Size and Forecast, By Product & Service, 2019 - 2032 (US$ Million)
      • 13.4.10.4. India Market Size and Forecast, By Type of Testing, 2019 - 2032 (US$ Million)
      • 13.4.10.5. India Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
      • 13.4.10.6. India Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 13.4.10.7. India Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 13.4.10.8. India Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 13.4.11. China
      • 13.4.11.1. Overview
      • 13.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 13.4.11.3. China Market Size and Forecast, By Product & Service, 2019 - 2032 (US$ Million)
      • 13.4.11.4. China Market Size and Forecast, By Type of Testing, 2019 - 2032 (US$ Million)
      • 13.4.11.5. China Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
      • 13.4.11.6. China Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 13.4.11.7. China Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 13.4.11.8. China Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 13.4.12. Japan
      • 13.4.12.1. Overview
      • 13.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 13.4.12.3. Japan Market Size and Forecast, By Product & Service, 2019 - 2032 (US$ Million)
      • 13.4.12.4. Japan Market Size and Forecast, By Type of Testing, 2019 - 2032 (US$ Million)
      • 13.4.12.5. Japan Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
      • 13.4.12.6. Japan Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 13.4.12.7. Japan Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 13.4.12.8. Japan Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 13.4.13. South Korea
      • 13.4.13.1. Overview
      • 13.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 13.4.13.3. South Korea Market Size and Forecast, By Product & Service, 2019 - 2032 (US$ Million)
      • 13.4.13.4. South Korea Market Size and Forecast, By Type of Testing, 2019 - 2032 (US$ Million)
      • 13.4.13.5. South Korea Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
      • 13.4.13.6. South Korea Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 13.4.13.7. South Korea Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 13.4.13.8. South Korea Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 13.4.14. Australia
      • 13.4.14.1. Overview
      • 13.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 13.4.14.3. Australia Market Size and Forecast, By Product & Service, 2019 - 2032 (US$ Million)
      • 13.4.14.4. Australia Market Size and Forecast, By Type of Testing, 2019 - 2032 (US$ Million)
      • 13.4.14.5. Australia Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
      • 13.4.14.6. Australia Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 13.4.14.7. Australia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 13.4.14.8. Australia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 13.4.15. Thailand
      • 13.4.15.1. Overview
      • 13.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 13.4.15.3. Thailand Market Size and Forecast, By Product & Service, 2019 - 2032 (US$ Million)
      • 13.4.15.4. Thailand Market Size and Forecast, By Type of Testing, 2019 - 2032 (US$ Million)
      • 13.4.15.5. Thailand Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
      • 13.4.15.6. Thailand Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 13.4.15.7. Thailand Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 13.4.15.8. Thailand Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 13.4.16. Indonesia
      • 13.4.16.1. Overview
      • 13.4.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 13.4.16.3. Indonesia Market Size and Forecast, By Product & Service, 2019 - 2032 (US$ Million)
      • 13.4.16.4. Indonesia Market Size and Forecast, By Type of Testing, 2019 - 2032 (US$ Million)
      • 13.4.16.5. Indonesia Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
      • 13.4.16.6. Indonesia Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 13.4.16.7. Indonesia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 13.4.16.8. Indonesia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 13.4.17. Philippines
      • 13.4.17.1. Overview
      • 13.4.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 13.4.17.3. Philippines Market Size and Forecast, By Product & Service, 2019 - 2032 (US$ Million)
      • 13.4.17.4. Philippines Market Size and Forecast, By Type of Testing, 2019 - 2032 (US$ Million)
      • 13.4.17.5. Philippines Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
      • 13.4.17.6. Philippines Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 13.4.17.7. Philippines Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 13.4.17.8. Philippines Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 13.4.18. Rest of APAC
      • 13.4.18.1. Overview
      • 13.4.18.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 13.4.18.3. Rest of APAC Market Size and Forecast, By Product & Service, 2019 - 2032 (US$ Million)
      • 13.4.18.4. Rest of APAC Market Size and Forecast, By Type of Testing, 2019 - 2032 (US$ Million)
      • 13.4.18.5. Rest of APAC Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
      • 13.4.18.6. Rest of APAC Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 13.4.18.7. Rest of APAC Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 13.4.18.8. Rest of APAC Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 13.5. Latin America
    • 13.5.1. Overview
    • 13.5.2. Infectious Disease Diagnostic Key Manufacturers in Latin America
    • 13.5.3. Latin America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 13.5.4. Latin America Market Size and Forecast, By Product & Service, 2019 - 2032 (US$ Million)
    • 13.5.5. Latin America Market Size and Forecast, By Type of Testing, 2019 - 2032 (US$ Million)
    • 13.5.6. Latin America Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
    • 13.5.7. Latin America Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
    • 13.5.8. Latin America Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 13.5.9. Latin America Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 13.5.10. Brazil
      • 13.5.10.1. Overview
      • 13.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 13.5.10.3. Brazil Market Size and Forecast, By Product & Service, 2019 - 2032 (US$ Million)
      • 13.5.10.4. Brazil Market Size and Forecast, By Type of Testing, 2019 - 2032 (US$ Million)
      • 13.5.10.5. Brazil Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
      • 13.5.10.6. Brazil Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 13.5.10.7. Brazil Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 13.5.10.8. Brazil Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 13.5.11. Mexico
      • 13.5.11.1. Overview
      • 13.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 13.5.11.3. Mexico Market Size and Forecast, By Product & Service, 2019 - 2032 (US$ Million)
      • 13.5.11.4. Mexico Market Size and Forecast, By Type of Testing, 2019 - 2032 (US$ Million)
      • 13.5.11.5. Mexico Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
      • 13.5.11.6. Mexico Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 13.5.11.7. Mexico Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 13.5.11.8. Mexico Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 13.5.12. Argentina
      • 13.5.12.1. Overview
      • 13.5.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 13.5.12.3. Argentina Market Size and Forecast, By Product & Service, 2019 - 2032 (US$ Million)
      • 13.5.12.4. Argentina Market Size and Forecast, By Type of Testing, 2019 - 2032 (US$ Million)
      • 13.5.12.5. Argentina Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
      • 13.5.12.6. Argentina Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 13.5.12.7. Argentina Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 13.5.12.8. Argentina Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 13.5.13. Colombia
      • 13.5.13.1. Overview
      • 13.5.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 13.5.13.3. Colombia Market Size and Forecast, By Product & Service, 2019 - 2032 (US$ Million)
      • 13.5.13.4. Colombia Market Size and Forecast, By Type of Testing, 2019 - 2032 (US$ Million)
      • 13.5.13.5. Colombia Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
      • 13.5.13.6. Colombia Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 13.5.13.7. Colombia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 13.5.13.8. Colombia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 13.5.14. Rest of LATAM
      • 13.5.14.1. Overview
      • 13.5.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 13.5.14.3. Rest of LATAM Market Size and Forecast, By Product & Service, 2019 - 2032 (US$ Million)
      • 13.5.14.4. Rest of LATAM Market Size and Forecast, By Type of Testing, 2019 - 2032 (US$ Million)
      • 13.5.14.5. Rest of LATAM Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
      • 13.5.14.6. Rest of LATAM Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 13.5.14.7. Rest of LATAM Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 13.5.14.8. Rest of LATAM Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 13.6. Middle East and Africa
    • 13.6.1. Overview
    • 13.6.2. Infectious Disease Diagnostic Key Manufacturers in Middle East and Africa
    • 13.6.3. Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 13.6.4. Middle East and Africa Market Size and Forecast, By Product & Service, 2019 - 2032 (US$ Million)
    • 13.6.5. Middle East and Africa Market Size and Forecast, By Type of Testing, 2019 - 2032 (US$ Million)
    • 13.6.6. Middle East and Africa Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
    • 13.6.7. Middle East and Africa Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
    • 13.6.8. Middle East and Africa Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 13.6.9. Middle East and Africa Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 13.6.10. Saudi Arabia
      • 13.6.10.1. Overview
      • 13.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 13.6.10.3. Saudi Arabia Market Size and Forecast, By Product & Service, 2019 - 2032 (US$ Million)
      • 13.6.10.4. Saudi Arabia Market Size and Forecast, By Type of Testing, 2019 - 2032 (US$ Million)
      • 13.6.10.5. Saudi Arabia Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
      • 13.6.10.6. Saudi Arabia Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 13.6.10.7. Saudi Arabia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 13.6.10.8. Saudi Arabia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 13.6.11. United Arab Emirates
      • 13.6.11.1. Overview
      • 13.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 13.6.11.3. United Arab Emirates Market Size and Forecast, By Product & Service, 2019 - 2032 (US$ Million)
      • 13.6.11.4. United Arab Emirates Market Size and Forecast, By Type of Testing, 2019 - 2032 (US$ Million)
      • 13.6.11.5. United Arab Emirates Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
      • 13.6.11.6. United Arab Emirates Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 13.6.11.7. United Arab Emirates Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 13.6.11.8. United Arab Emirates Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 13.6.12. Israel
      • 13.6.12.1. Overview
      • 13.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 13.6.12.3. Israel Market Size and Forecast, By Product & Service, 2019 - 2032 (US$ Million)
      • 13.6.12.4. Israel Market Size and Forecast, By Type of Testing, 2019 - 2032 (US$ Million)
      • 13.6.12.5. Israel Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
      • 13.6.12.6. Israel Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 13.6.12.7. Israel Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 13.6.12.8. Israel Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 13.6.13. Turkey
      • 13.6.13.1. Overview
      • 13.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 13.6.13.3. Turkey Market Size and Forecast, By Product & Service, 2019 - 2032 (US$ Million)
      • 13.6.13.4. Turkey Market Size and Forecast, By Type of Testing, 2019 - 2032 (US$ Million)
      • 13.6.13.5. Turkey Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
      • 13.6.13.6. Turkey Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 13.6.13.7. Turkey Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 13.6.13.8. Turkey Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 13.6.14. Algeria
      • 13.6.14.1. Overview
      • 13.6.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 13.6.14.3. Algeria Market Size and Forecast, By Product & Service, 2019 - 2032 (US$ Million)
      • 13.6.14.4. Algeria Market Size and Forecast, By Type of Testing, 2019 - 2032 (US$ Million)
      • 13.6.14.5. Algeria Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
      • 13.6.14.6. Algeria Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 13.6.14.7. Algeria Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 13.6.14.8. Algeria Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 13.6.15. Egypt
      • 13.6.15.1. Overview
      • 13.6.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 13.6.15.3. Egypt Market Size and Forecast, By Product & Service, 2019 - 2032 (US$ Million)
      • 13.6.15.4. Egypt Market Size and Forecast, By Type of Testing, 2019 - 2032 (US$ Million)
      • 13.6.15.5. Egypt Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
      • 13.6.15.6. Egypt Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 13.6.15.7. Egypt Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 13.6.15.8. Egypt Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 13.6.16. Rest of MEA
      • 13.6.16.1. Overview
      • 13.6.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 13.6.16.3. Rest of MEA Market Size and Forecast, By Product & Service, 2019 - 2032 (US$ Million)
      • 13.6.16.4. Rest of MEA Market Size and Forecast, By Type of Testing, 2019 - 2032 (US$ Million)
      • 13.6.16.5. Rest of MEA Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
      • 13.6.16.6. Rest of MEA Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 13.6.16.7. Rest of MEA Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 13.6.16.8. Rest of MEA Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)

14. Key Vendor Analysis- Infectious Disease Diagnostic Industry

  • 14.1. Competitive Dashboard
  • 14.2. Company Profiles
    • 14.2.1. F. Hoffmann-La Roche Ltd.
    • 14.2.2. Abbott
    • 14.2.3. Biomerieux
    • 14.2.4. Siemens Healthineers Ag
    • 14.2.5. Danaher
    • 14.2.6. Thermo Fisher Scientific Inc.
    • 14.2.7. Hologic, Inc.
    • 14.2.8. Becton, Dickinson And Company
    • 14.2.9. Revvity
    • 14.2.10. Qiagen
    • 14.2.11. Seegene Inc.
    • 14.2.12. Quidelortho Corporation
    • 14.2.13. Grifols, S.A.
    • 14.2.14. Diasorin S.P.A.
    • 14.2.15. Bio-Rad Laboratories, Inc.
    • 14.2.16. Sysmex Corporation
    • 14.2.17. Others

15. 360 Degree Analyst View

16. Appendix

  • 16.1. Research Methodology
  • 16.2. References
  • 16.3. Abbreviations
  • 16.4. Disclaimer
  • 16.5. Contact Us